Metastatic Breast Cancer
From the Journals
Weight Loss Drugs Cut Cancer Risk in Diabetes Patients
Researchers examine electronic health records of patients who had type 2 diabetes, no prior diagnosis of obesity-related cancers, and had been...
From the Journals
Urticaria Linked to Higher Cancer Risk, Study Finds
Researchers compare the incident cancer risk between patients with urticaria and the general population using data from Danish healthcare...
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Feature
Cancer Drug Shortages Continue in the US, Survey Finds
Not having enough of a significant spectrum of generic chemotherapies and supportive care medications is an ongoing issue, NCCN surveys suggest....
Conference Coverage
Neurofilament Light Chain Detects Early Chemotherapy-Related Neurotoxicity
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
Feature
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?
The number of community practices acquired by hospitals nearly tripled from 2010 to 2020, according to a report from COA.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...
News from the FDA/CDC
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid Tumors
The approval was based on a single-arm open-label trial in 88 adults with locally advanced or metastatic NTRK gene fusion solid tumors....
From the Journals
Are Children Born Through ART at Higher Risk for Cancer?
A slight increase in the risk for leukemia was observed in children conceived through IVF or ICSI.
Conference Coverage
T-DXd Moves Toward First Line for HER2-Low Metastatic BC
New results from DESTINY trials support use of the antibody-drug conjugate earlier in the treatment algorithm for cancers expressing even the...